Skip to main content

Pure Autonomic Failure

  • Chapter
  • First Online:
Autonomic Nervous System and Sleep
  • 759 Accesses

Abstract

Bradbury and Eggleston, in 1925, provided the initial account of pure autonomic failure (PAF). The consensus statement in 1996 defined it as an idiopathic sporadic disorder with orthostatic hypotension, including widespread autonomic dysfunction and reduced supine norepinephrine levels without other neurological features. Autonomic investigations were consistent with efferent, likely postganglionic, adrenergic failure. Because patients with multiple system atrophy, a neurodegenerative disorder with poor prognosis, mimicked PAF during the initial few years after onset, clinical investigators in the 1980s and 1990s focused on developing tests that distinguished PAF (postganglionic dysfunction) from multiple system atrophy (preganglionic dysfunction). Earlier neuropathological studies observed Lewy bodies in the substantia nigra, locus coeruleus, dorsal motor nucleus of the vagus, intermediolateral column cells of the spinal cord, and sympathetic ganglia. Later studies reported α-synuclein aggregates in PAF, idiopathic Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy, thus challenging the existence of PAF as an independent entity. PAF patients have a relatively benign course but with severe symptoms. Failure of nonpharmacologic modalities such as rapid water drinking, abdominal compression, and physical counter maneuvers requires use of drugs to reduce the impact of orthostatic hypotension. Midodrine and droxidopa are FDA-approved drugs, and fludrocortisone has been prescribed off label since 1959. Appropriate specialty consultation is warranted in patients with severe bladder or bowel disturbances.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wagner HN Jr. Orthostatic hypotension. Bull Johns Hopkins Hosp. 1959;105:322–59.

    Google Scholar 

  2. Bradbury S, Eggleston C. Postural hypotension: a report of 3 cases. Am Heart J. 1925;1(1):74–86.

    Article  Google Scholar 

  3. Barker NW. Postural hypotension: report of a case and review of the literature. Med Clin North Am. 1933;16:1301–12.

    Google Scholar 

  4. Luft R, Von Euler US. Two cases of postural hypotension showing a deficiency in release of nor-epinephrine and epinephrine. J Clin Invest. 1953;32:1065–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Hickler RB, Thompson GR, Fox LM, Hamlin JT III. Successful treatment of orthostatic hypotension with 9-alpha fluorohydrocortisone. N Engl J Med. 1959;261:788–91.

    Article  CAS  PubMed  Google Scholar 

  6. Young RH. Association of postural hypotension with sympathetic nervous system dysfunction: case report, with review of neurologic features associated with postural hypotension. Ann Intern Med. 1941;15:910–6.

    Article  Google Scholar 

  7. Shy AM, Drager GA. A neurological syndrome associated with orthstatic hypotension. A clinical-pathological study. Arch Neurol. 1960;2:511–27.

    Article  CAS  PubMed  Google Scholar 

  8. Johnson RM, Lee CJ, Oppenheimer DR, Spalding JM. Autonomic failure with orthostatic hypotension due to intermediolateral column degeneration. Q J Med. 1966;35(138):276–95.

    CAS  PubMed  Google Scholar 

  9. Graham JG, Oppenheimer DR. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry. 1969;32(1):28–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Goodall MC, Harlan WR Jr, Alton H. Decreased noradrenaline (norepinephrine) synthesis in neurogenic orthostatic hypotension. Circulation. 1968;38(3):592–603.

    Article  CAS  PubMed  Google Scholar 

  11. Kontos HA, Richardson DW, Norrell JE. Norephinephrine depletion in idiopathic orthostatic hypotension. Ann Intern Med. 1975;82(3):336–61.

    Article  CAS  PubMed  Google Scholar 

  12. Ziegler MG, Lake CR, Kopin IJ. The sympathetic-nervous-system defect in primary orthostatic hypotension. N Engl J Med. 1977;296(6):293–7.

    Article  CAS  PubMed  Google Scholar 

  13. Freeman R. Pure autonomic failure: an immaculate misconception? Neurology. 2004;63(6):953–4.

    Article  PubMed  Google Scholar 

  14. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology. 1996;46(5):1470.

    Google Scholar 

  15. Arbogast SD, Alshekhlee A, Hussain Z, McNeeley K, Chelimsky TC. Hypotension unawareness in profound orthostatic hypotension. Am J Med. 2009;122(6):574–80.

    Article  PubMed  Google Scholar 

  16. Khurana RK. Orthostatic hypotension. NY State J Med. 1988;88(11):570–2.

    CAS  Google Scholar 

  17. Chaudhuri KR, Maule S, Thomaides T, Pavitt D, Mathias CJ. Alcohol ingestion lowers supine blood pressure, causes splanchnic vasodilatation and worsens postural hypotension in primary autonomic failure. J Neurol. 1994;241(3):145–52.

    Article  CAS  PubMed  Google Scholar 

  18. Low PA, Opfer-Gehrking TL, McPhee BR, Fealey RD, Benarroch EE, Willner CL, et al. Prospective evaluation of clinical characteristics of orthostatic hypotension. Mayo Clin Proc. 1995;70(7):617–22.

    Article  CAS  PubMed  Google Scholar 

  19. Mathias CJ, Mallipeddi R, Bleasdale-Barr K. Symptoms associated with orthostatic hypotension in pure autonomic failure and multiple system atrophy. J Neurol. 1999;246(10):893–8.

    Article  CAS  PubMed  Google Scholar 

  20. Robertson D, Kincaid DW, Haile V, Robertson RM. The head and neck discomfort of autonomic failure: an unrecognized aetiology of headache. Clin Auton Res. 1994;4(3):99–103.

    Article  CAS  PubMed  Google Scholar 

  21. Khurana RK. Coat-hanger ache in orthostatic hypotension. Cephalalgia. 2012;32(10):731–7.

    Article  PubMed  Google Scholar 

  22. Kaufmann H, Malamut R, Norcliffe-Kaufmann L, Rosa K, Freeman R. The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale. Clin Auton Res. 2012;22(2):79–90.

    Article  PubMed  Google Scholar 

  23. Gil-Diaz A, Conde-Martel A, Betancor-Leon P. A 69-year-old man with excessive sweating of the right hemithorax. BMJ Case Rep. 2011;2011:bcr0320113970.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Yamanaka Y, Sakakibara R, Asahina M, Uchiyama T, Liu Z, Yamamoto T, et al. Chronic intestinal pseudo-obstruction as the initial feature of pure autonomic failure. J Neurol Neurosurg Psychiatry. 2006;77(6):800.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Sakakibara R, Hattori T, Uchiyama T, Asahina M, Yamanishi T. Micturitional disturbance in pure autonomic failure. Neurology. 2000;54(2):499–501.

    Article  CAS  PubMed  Google Scholar 

  26. Isonaka R, Holmes C, Cook GA, Sullivan P, Sharabi Y, Goldstein DS. Pure autonomic failure without synucleinopathy. Clin Auton Res. 2017;27(2):97–101.

    Article  PubMed  Google Scholar 

  27. Hishikawa N, Hashizume Y, Hirayama M, Imamura K, Washimi Y, Koike Y, et al. Brainstem-type Lewy body disease presenting with progressive autonomic failure and lethargy. Clin Auton Res. 2000;10(3):139–43.

    Article  CAS  PubMed  Google Scholar 

  28. Kashihara K, Ohno M, Kawada S, Imamura T. Frequent nocturnal vocalization in pure autonomic failure. J Int Med Res. 2008;36(3):489–95.

    Article  CAS  PubMed  Google Scholar 

  29. Tulen JHM, Man in’t Veld AJ, van Steemis HG, Mechelse K. Sleep patterns and blood pressure variability in patients with pure autonomic failure. Clin Auton Res. 1991;1(4):309–15.

    Article  CAS  PubMed  Google Scholar 

  30. Plazzi G, Cortelli P, Montagna P, De Monte A, Corsini R, Contin M, et al. REM sleep behaviour disorder differentiates pure autonomic failure from multiple system atrophy with autonomic failure. J Neurol Neurosurg Psychiatry. 1998;64(5):683–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Weyer A, Minnerop M, Abele M, Klockgether T. REM sleep behavioral disorder in pure autonomic failure (PAF). Neurology. 2006;66(4):608–9.

    Article  PubMed  Google Scholar 

  32. Miglis MG, Muppidi S, During E, Jaradeh S. A case series of REM sleep behavior disorder in pure autonomic failure. Clin Auton Res. 2017;27(1):41–4.

    Article  PubMed  Google Scholar 

  33. St Louis EK, Boeve AR, Boeve BF. REM sleep behavior disorder in Parkinson’s Disease and other synucleinopathies. Mov Disord. 2017;32(5):645–58.

    Article  CAS  PubMed  Google Scholar 

  34. Barone DA, Henchcliffe C. Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies. Clin Neurophysiol. 2018;129(8):1551–64.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Khurana RK, Russell C. The spoon test: a valid and reliable bedside test to assess sudomotor function. Clin Auton Res. 2017;27(2):91–5.

    Article  PubMed  Google Scholar 

  36. Mannen T, Iwata M, Toyokura Y, Nagashima K. The Onuf’s nucleus and the external anal sphincter muscles in amyotrophic lateral sclerosis and Shy-Drager syndrome. Acta Neuropathol. 1982;58(4):255–60.

    Article  CAS  PubMed  Google Scholar 

  37. Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017;264(8):1567–82.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Shannon J, Jordan J, Costa F, Robertson RM, Biaggioni I. The hypertension of autonomic failure and its treatment. Hypertension. 1997;30(5):1062–7.

    Article  CAS  PubMed  Google Scholar 

  39. Vagaonescu TD, Saadia D, Tuhrim S, Phillips RA, Kaufmann H. Hypertensive cardiovascular damage in patients with primary autonomic failure. Lancet. 2000;355(9205):725–6.

    Article  CAS  PubMed  Google Scholar 

  40. Garland EM, Gamboa A, Okamoto L, Raj SR, Black BK, Davis TL, et al. Renal impairment of pure autonomic failure. Hypertension. 2009;54(5):1057–61.

    Article  CAS  PubMed  Google Scholar 

  41. Norcliffe-Kaufmann L, Kaufmann H. Is ambulatory blood pressure monitoring useful in patients with chronic autonomic failure? Clin Auton Res. 2014;24(4):189–92.

    Article  PubMed  Google Scholar 

  42. Heims HC, Critchley HD, Martin NH, Jager HR, Mathias CJ, Cipolotti L. Cognitive functioning in orthostatic hypotension due to pure autonomic failure. Clin Auton Res. 2006;16(2):113–20.

    Article  PubMed  Google Scholar 

  43. Silveira-Moriyama L, Mathias C, Mason L, Best C, Quinn NP, Lees AJ. Hyposmia in pure autonomic failure. Neurology. 2009;72(19):1677–81.

    Article  CAS  PubMed  Google Scholar 

  44. Kaufmann H, Norcliffe-Kaufmann L, Palma JA, Biaggioni I, Low PA, Singer W, et al. Natural history of pure autonomic failure: a United States prospective cohort. Ann Neurol. 2017;81(2):287–97.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Bradbury S, Eggleston C. Postural hypotension: an autopsy upon a case. Am Heart J. 1927;3:105–6.

    Article  Google Scholar 

  46. Vanderhaeghen JJ, Perier O, Sternon JE. Pathological findings in idiopathic orthostatic hypotension. Its relationship with Parkinson’s disease. Arch Neurol. 1970;22(3):207–14.

    Article  CAS  PubMed  Google Scholar 

  47. Roessmann U, Van den Noort S, McFarland DE. Idiopathic orthostatic hypotension. Arch Neurol. 1971;24(6):503–10.

    Article  CAS  PubMed  Google Scholar 

  48. Oppenheimer DR. Lateral horn cells in progressive autonomic failure. J Neurol Sci. 1980;46(3):393–404.

    Article  CAS  PubMed  Google Scholar 

  49. van Ingelghem E, van Zandijcke M, Lammens M. Pure autonomic failure: a new case with clinical, biochemical, and necropsy data. J Neurol Neurosurg Psychiatry. 1994;57(6):745–7.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Terao Y, Takeda K, Sakuta M, Nemoto T, Takemura T, Kawai M. Pure progressive autonomic failure: a clinicopathological study. Eur Neurol. 1993;33(6):409–15.

    Article  CAS  PubMed  Google Scholar 

  51. Rajput AH, Rozdilsky B. Dysautonomia in parkinsonism: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1976;39(11):1092–100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Hague K, Lento P, Morgello S, Caro S, Kaufmann H. The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature. Acta Neuropathol. 1997;94(2):192–6.

    Article  CAS  PubMed  Google Scholar 

  53. Arai K, Kato N, Kashiwado K, Hattori T. Pure autonomic failure in association with human alpha-synucleinopathy. Neurosci Lett. 2000;296(2–3):171–3.

    Article  CAS  PubMed  Google Scholar 

  54. Matthews MR. Assessing the peripheral ganglia in autonomic failure. In: Bannister R, editor. Autonomic failure: a textbook of clinical disorders of the autonomic nervous system. 2nd ed. Oxford UK: Oxford University Press; 1988. p. 511–43.

    Google Scholar 

  55. Bannister R, Crowe R, Eames R, Burnstock G. Adrenergic innervation in autonomic failure. Neurology. 1981;31(12):1501–6.

    Article  CAS  PubMed  Google Scholar 

  56. Kanda T, Tomimitsu H, Yokota T, Ohkoshi N, Hayashi M, Mizusawa H. Unmyelinated nerve fibers in sural nerve in pure autonomic failure. Ann Neurol. 1998;43(2):267–71.

    Article  CAS  PubMed  Google Scholar 

  57. Kurashiki-Osaka T, Adachi T, Nakayasu H, Nakashima K. Alpha-synuclein accumulation in a patient with Auerbach’s plexus of pure autonomic failure. Intern Med. 2014;53(19):2261.

    Article  PubMed  Google Scholar 

  58. Masuda H, Asahina M, Oide T, Wakita H, Sekiguchi Y, Araki N, et al. Antemortem detection of colonic alpha-synuclein pathology in a patient with pure autonomic failure. J Neurol. 2014;261(12):2451–2.

    Article  PubMed  Google Scholar 

  59. Donadio V, Cortelli P, Elam M, Di Stasi V, Montagna P, Holmberg B, et al. Autonomic innervation in multiple system atrophy and pure autonomic failure. J Neurol Neurosurg Psychiatry. 2010;81(12):1327–35.

    Article  CAS  PubMed  Google Scholar 

  60. Shishido T, Ikemura M, Obi T, Yamazaki K, Terada T, Sugiura A, et al. Alpha-synuclein accumulation in skin nerve fibers revealed by skin biopsy in pure autonomic failure. Neurology. 2010;74(7):608–10.

    Article  CAS  PubMed  Google Scholar 

  61. Donadio V, Incensi A, Cortelli P, Giannoccaro MP, Jaber MA, Baruzzi A, et al. Skin sympathetic fiber alpha-synuclein deposits: a potential biomarker for pure autonomic failure. Neurology. 2013;80(8):725–32.

    Article  CAS  PubMed  Google Scholar 

  62. Donadio V, Incensi A, El-Agnaf O, Rizzo G, Vaikath N, Del Sorbo F, et al. Skin alpha-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study. Sci Rep. 2018;8(1):14246.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Donadio V, Incensi A, Piccinini C, Cortelli P, Giannoccaro MP, Baruzzi A, et al. Skin nerve misfolded alpha-synuclein in pure autonomic failure and Parkinson disease. Ann Neurol. 2016;79(2):306–16.

    Article  CAS  PubMed  Google Scholar 

  64. Klein RL, Baggett JM, Thureson-Klein A, Langford HG. Idiopathic orthostatic hypotension: circulating noradrenaline and ultrastructure of saphenous vein. J Auton Nerv Syst. 1980;2(3):205–22.

    Article  CAS  PubMed  Google Scholar 

  65. Guo L, Esler MD, Sari C, Phillips S, Lambert EA, Straznicky NE, et al. Does sympathetic dysfunction occur before denervation in pure autonomic failure? Clin Sci (Lond). 2018;132(1):1–16.

    Article  CAS  Google Scholar 

  66. Khurana RK. Dysautonomia. In: Schuster MM, Crowell MD, Koch KL, editors. Schuster Atlas of gastrointestinal motility. Hamilton: BC Decker, Inc.; 2002. p. 335–51.

    Google Scholar 

  67. Assessment: clinical autonomic testing report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 1996;46(3):873–80.

    Google Scholar 

  68. Khurana RK, Nicholas EM. Head-up tilt table test: how far and how long? Clin Auton Res. 1996;6(6):335–41.

    Article  CAS  PubMed  Google Scholar 

  69. Vogel ER, Sandroni P, Low PA. Blood pressure recovery from Valsalva maneuver in patients with autonomic failure. Neurology. 2005;65(10):1533–7.

    Article  PubMed  Google Scholar 

  70. Denq JC, O’Brien PC, Low PA. Normative data on phases of the Valsalva maneuver. J Clin Neurophysiol. 1998;15(6):535–40.

    Article  CAS  PubMed  Google Scholar 

  71. Khurana RK. Valsalva ratio: a noninvasive and quantifiable test of vagal function. Trans Am Neurol Assoc. 1981;106:107–9.

    Google Scholar 

  72. Ludbrook J, Vincent A, Walsh JA. Effects of mental arithmetic on arterial pressure and hand blood flow. Clin Exp Pharmacol Physiol. 1975;(Suppl 2):67–70.

    Google Scholar 

  73. Khurana RK. Cold face test: adrenergic phase. Clin Auton Res. 2007;17(4):211–6.

    Article  PubMed  Google Scholar 

  74. Khurana RK, Wu R. The cold face test: a non-baroreflex mediated test of cardiac vagal function. Clin Auton Res. 2006;16(3):202–7.

    Article  PubMed  Google Scholar 

  75. Masaoka S, Lev-Ran A, Hill LR, Vakil G, Hon EH. Heart rate variability in diabetes: relationship to age and duration of the disease. Diabetes Care. 1985;8(1):64–8.

    Article  CAS  PubMed  Google Scholar 

  76. Fealey RD, Low PA, Thomas JE. Thermoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin Proc. 1989;64(6):617–28.

    Article  CAS  PubMed  Google Scholar 

  77. Polinsky RJ, Taylor IL, Chew P, Weise V, Kopin IJ. Pancreatic polypeptide responses to hypoglycemia in chronic autonomic failure. J Clin Endocrinol Metab. 1982;54(1):48–52.

    Article  CAS  PubMed  Google Scholar 

  78. Polinsky RJ, Taylor IL, Weise V, Kopin IJ. Gastrin responses in patients with adrenergic insufficiency. J Neurol Neurosurg Psychiatry. 1988;51(1):67–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Khurana RK, Nelson E, Azzarelli B, Garcia JH. Shy-Drager syndrome: diagnosis and treatment of cholinergic dysfunction. Neurology. 1980;30(8):805–9.

    Article  CAS  PubMed  Google Scholar 

  80. Khurana RK. Cholinergic dysfunction in Shy-Drager syndrome: effect of the parasympathomimetic agent, bethanechol. Clin Auton Res. 1994;4(1–2):5–13.

    Article  CAS  PubMed  Google Scholar 

  81. Ogata A, Kitano M, Sano H. Cevimeline hydrochloride improved cholinergic dysfunction in a patient with pure autonomic failure. J Neurol. 2006;253(1):119–20.

    Article  PubMed  Google Scholar 

  82. Goldstein DS, Sewell L. Olfactory dysfunction in pure autonomic failure: implications for the pathogenesis of Lewy body diseases. Parkinsonism Relat Disord. 2009;15(7):516–20.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Eardley I, Quinn NP, Fowler CJ, Kirby RS, Parkhouse HF, Marsden CD, et al. The value of urethral sphincter electromyography in the differential diagnosis of parkinsonism. Br J Urol. 1989;64(4):360–2.

    Article  CAS  PubMed  Google Scholar 

  84. Vodusek DB. Sphincter EMG and differential diagnosis of multiple system atrophy. Mov Disord. 2001;16(4):600–7.

    Article  CAS  PubMed  Google Scholar 

  85. Nahm F, Freeman R. Sphincter electromyography and multiple system atrophy. Muscle Nerve. 2003;28(1):18–26.

    Article  PubMed  Google Scholar 

  86. Chelban V, Bocchetta M, Hassanein S, Haridy NA, Houlden H, Rohrer JD. An update on advances in magnetic resonance imaging of multiple system atrophy. J Neurol. 2019;266(4):1036–45.

    Article  PubMed  Google Scholar 

  87. Kondo T, Inoue H, Usui T, Mimori T, Tomimoto H, Vernino S, et al. Autoimmune autonomic ganglionopathy with Sjogren’s syndrome: significance of ganglionic acetylcholine receptor antibody and therapeutic approach. Auton Neurosci. 2009;146(1–2):33–5.

    Article  CAS  PubMed  Google Scholar 

  88. Pandit A, Gangurde S, Gupta SB. Autonomic failure in primary amyloidosis. J Assoc Physicians India. 2008;56:995–6.

    PubMed  Google Scholar 

  89. Khurana RK. Paraneoplastic autonomic dysfunction. In: Robertson D, Biaggioni I, Burnstock G, Low PA, Paton JFR, editors. Primer on the autonomic Nervous System. London: Academic Press; 2012. p. 593–6.

    Chapter  Google Scholar 

  90. Koike H, Watanabe H, Sobue G. The spectrum of immune-mediated autonomic neuropathies: insights from the clinicopathological features. J Neurol Neurosurg Psychiatry. 2013;84(1):98–106.

    Article  PubMed  Google Scholar 

  91. Goldstein DS, Holmes C, Dendi R, Li ST, Brentzel S, Vernino S. Pandysautonomia associated with impaired ganglionic neurotransmission and circulating antibody to the neuronal nicotinic receptor. Clin Auton Res. 2002;12(4):281–5.

    Article  PubMed  Google Scholar 

  92. Kontos HA, Richardson DW, Norvell JE. Mechanisms of circulatory dysfunction in orthostatic hypotension. Trans Am Clin Climatol Assoc. 1976;87:26–35.

    CAS  PubMed  PubMed Central  Google Scholar 

  93. Polinsky RJ, Kopin IJ, Ebert MH, Weise V. Pharmacologic distinction of different orthostatic hypotension syndromes. Neurology. 1981;31(1):1–7.

    Article  CAS  PubMed  Google Scholar 

  94. Macmillan AL, Spalding JM. Human sweating response to electrophoresed acetylcholine: a test of postganglionic sympathetic function. J Neurol Neurosurg Psychiatry. 1969;32(2):155–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  95. Low PA, Caskey PE, Tuck RR, Fealey RD, Dyck PJ. Quantitative sudomotor axon reflex test in normal and neuropathic subjects. Ann Neurol. 1983;14(5):573–80.

    Article  CAS  PubMed  Google Scholar 

  96. Chung EJ, Kim SJ. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Lewy body-related disorders: a literature review. J Mov Disord. 2015;8(2):55–66.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Sakakibara R, Tateno F, Aiba Y, Ogata T, Kishi M, Terada H, et al. MIBG myocardial scintigraphy identifies premotor PD/DLB during a negative DAT scan period: second report. Mov Disord Clin Pract. 2019;6(1):46–50.

    Article  PubMed  Google Scholar 

  98. Kaufmann H, Oribe E, Miller M, Knott P, Wiltshire-Clement M, Yahr MD. Hypotension-induced vasopressin release distinguishes between pure autonomic failure and multiple system atrophy with autonomic failure. Neurology. 1992;42(3 Pt 1):590–3.

    Article  CAS  PubMed  Google Scholar 

  99. Williams TD, Lightman SL, Bannister R. Vasopressin secretion in progressive autonomic failure: evidence for defective afferent cardiovascular pathways. J Neurol Neurosurg Psychiatry. 1985;48(3):225–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  100. Thomaides TN, Chaudhuri KR, Maule S, Watson L, Marsden CD, Mathias CJ. Growth hormone response to clonidine in central and peripheral primary autonomic failure. Lancet. 1992;340(8814):263–6.

    Article  CAS  PubMed  Google Scholar 

  101. Kimber JR, Watson L, Mathias CJ. Distinction of idiopathic Parkinson’s disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine. Lancet. 1997;349(9069):1877–81.

    Article  CAS  PubMed  Google Scholar 

  102. Cohen J, Low P, Fealey R, Sheps S, Jiang NS. Somatic and autonomic function in progressive autonomic failure and multiple system atrophy. Ann Neurol. 1987;22(6):692–9.

    Article  CAS  PubMed  Google Scholar 

  103. Meredith IT, Eisenhofer G, Lambert GW, Jennings GL, Thompson J, Esler MD. Plasma norepinephrine responses to head-up tilt are misleading in autonomic failure. Hypertension. 1992;19(6 Pt 2):628–33.

    Article  CAS  PubMed  Google Scholar 

  104. Tranchant C, Guiraud-Chaumeil C, Echaniz-Laguna A, Warter JM. Is clonidine growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson’s disease? J Neurol. 2000;247(11):853–6.

    Article  CAS  PubMed  Google Scholar 

  105. Kaufmann H, Nahm K, Purohit D, Wolfe D. Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology. 2004;63(6):1093–5.

    Article  PubMed  Google Scholar 

  106. Mabuchi N, Hirayama M, Koike Y, Watanabe H, Ito H, Kobayashi R, et al. Progression and prognosis in pure autonomic failure (PAF): comparison iwth multiple system atrophy. J Neurol Neurosurg Psychiatry. 2005;76:947–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Alves Do Rego C, Namer IJ, Marcel C, Lefebvre F, Lagha-Boukbiza O, Renaud M, et al. Prospective study of relevance of (123)I-MIBG myocardial scintigraphy and clonidine GH test to distinguish Parkinson’s disease and multiple system atrophy. J Neurol. 2018;265(9):2033–9.

    Article  CAS  PubMed  Google Scholar 

  108. Singer W, Berini SE, Sandroni P, Fealey RD, Coon EA, Suarez MD, et al. Pure autonomic failure: predictors of conversion to clinical CNS involvement. Neurology. 2017;88(12):1129–36.

    Article  PubMed  PubMed Central  Google Scholar 

  109. Kaufmann H, Palma JA. Neurogenic orthostatic hypotension: the very basics. Clin Auton Res. 2017;27(Suppl 1):39–43.

    Article  PubMed  PubMed Central  Google Scholar 

  110. Bannister R, Ardill L, Fentem P. An assessment of various methods of treatment of idiopathic orthostatic hypotension. Q J Med. 1969;38(152):377–95.

    CAS  PubMed  Google Scholar 

  111. Low PA. Neurogenic orthostatic hypotension: pathophysiology and diagnosis. Am J Manag Care. 2015;21(13 Suppl):s248–57.

    PubMed  Google Scholar 

  112. El-Sayed H, Hainsworth R. Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart. 1996;75(2):134–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  113. Jordan J, Shannon JR, Black BK, Ali Y, Farley M, Costa F, et al. The pressor response to water drinking in humans : a sympathetic reflex? Circulation. 2000;101(5):504–9.

    Article  CAS  PubMed  Google Scholar 

  114. Mills PB, Fung CK, Travlos A, Krassioukov A. Nonpharmacologic management of orthostatic hypotension: a systematic review. Arch Phys Med Rehabil. 2015;96(2):366–75. e6

    Article  PubMed  Google Scholar 

  115. van Lieshout JJ, ten Harkel AD, Wieling W. Physical manoeuvres for combating orthostatic dizziness in autonomic failure. Lancet. 1992;339(8798):897–8.

    Article  PubMed  Google Scholar 

  116. Harms MP, Wieling W, Colier WN, Lenders JW, Secher NH, van Lieshout JJ. Central and cerebrovascular effects of leg crossing in humans with sympathetic failure. Clin Sci (Lond). 2010;118(9):573–81.

    Article  Google Scholar 

  117. Schmid PG, Eckstein JW, Abboud FM. Effect of 9-alpha-fluorohydrocortisone on forearm vascular responses to norepinephrine. Circulation. 1966;34(4):620–6.

    Article  CAS  PubMed  Google Scholar 

  118. Chobanian AV, Volicer L, Tifft CP, Gavras H, Liang CS, Faxon D. Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. N Engl J Med. 1979;301(2):68–73.

    Article  CAS  PubMed  Google Scholar 

  119. Grijalva CG, Biaggioni I, Griffin MR, Shibao CA. Fludrocortisone is associated with a higher risk of all-cause hospitalizations compared with midodrine in patients with orthostatic hypotension. J Am Heart Assoc. 2017;6(10):e006848.

    Article  PubMed  PubMed Central  Google Scholar 

  120. Ten Harkel AD, Van Lieshout JJ, Wieling W. Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisone. J Intern Med. 1992;232(2):139–45.

    Article  PubMed  Google Scholar 

  121. Jankovic J, Gilden JL, Hiner BC, Kaufmann H, Brown DC, Coghlan CH, et al. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med. 1993;95(1):38–48.

    Article  CAS  PubMed  Google Scholar 

  122. Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA. 1997;277(13):1046–51.

    Article  CAS  PubMed  Google Scholar 

  123. Kaufmann H, Norcliffe-Kaufmann L, Palma JA. Droxidopa in neurogenic orthostatic hypotension. Expert Rev Cardiovasc Ther. 2015;13(8):875–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  124. Kachi T, Iwase S, Mano T, Saito M, Kunimoto M, Sobue I. Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activities in Shy-Drager syndrome. Neurology. 1988;38(7):1091–4.

    Article  CAS  PubMed  Google Scholar 

  125. Perez-Lloret S, Quarracino C, Otero-Losada M, Rascol O. Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases. Expert Opin Pharmacother. 2019;20(6):635–45.

    Article  CAS  PubMed  Google Scholar 

  126. Isaacson S, Vernino S, Ziemann A, Rowse GJ, Kalu U, White WB. Long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension. J Am Soc Hypertens. 2016;10(10):755–62.

    Article  CAS  PubMed  Google Scholar 

  127. Lahrmann H, Cortelli P, Hilz M, Mathias CJ, Struhal W, Tassinari M. EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur J Neurol. 2006;13(9):930–6.

    Article  CAS  PubMed  Google Scholar 

  128. Shibao C, Okamoto L, Biaggioni I. Pharmacotherapy of autonomic failure. Pharmacol Ther. 2012;134(3):279–86.

    Article  CAS  PubMed  Google Scholar 

  129. Biaggioni I. The pharmacology of autonomic failure: from hypotension to hypertension. Pharmacol Rev. 2017;69(1):53–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  130. Eschlbock S, Wenning G, Fanciulli A. Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms. J Neural Transm (Vienna). 2017;124(12):1567–605.

    Article  CAS  Google Scholar 

  131. Young TM, Mathias CJ. Treatment of supine hypertension in autonomic failure with gastrostomy feeding at night. Auton Neurosci. 2008;143(1–2):77–8.

    Article  PubMed  Google Scholar 

  132. Palma JA, Kaufmann H. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies. Mov Disord. 2018;33(3):372–90.

    Article  PubMed  PubMed Central  Google Scholar 

  133. Goldstein DS, Holmes C, Sato T, Bernson M, Mizrahi N, Imrich R, et al. Central dopamine deficiency in pure autonomic failure. Clin Auton Res. 2008;18(2):58–65.

    Article  PubMed  Google Scholar 

  134. Kaufmann H, Goldstein DS. Pure autonomic failure: a restricted Lewy body synucleinopathy or early Parkinson disease? Neurology. 2010;74(7):536–7.

    Article  PubMed  Google Scholar 

  135. Bousset L, Pieri L, Ruiz-Arlandis G, Gath J, Jensen PH, Habenstein B, et al. Structural and functional characterization of two alpha-synuclein strains. Nat Commun. 2013;4:2575.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

I thank Jacqueline Taylor for typing the manuscript and Lyn Jones, MA, ELS, for editorial assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ramesh K. Khurana .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Khurana, R.K. (2021). Pure Autonomic Failure. In: Chokroverty, S., Cortelli, P. (eds) Autonomic Nervous System and Sleep. Springer, Cham. https://doi.org/10.1007/978-3-030-62263-3_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-62263-3_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-62262-6

  • Online ISBN: 978-3-030-62263-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics